| Full Company Name | EMBRACING FUTURE HOLDINGS LIMITED |
|---|---|
| Incorporated In | SINGAPORE |
| Incorporated On | 19 Jul 2009 |
| ISIN Code | SGXE89830751 |
| Listing | Listed on 19 December 2018 on CATALIST |
| Listing Board | CATALIST |
| Trading Currency | SGD |
| Website | https://www.ebfholdings.com |
| [email protected] | |
| Telephone | 65 64820668 |
| Registered Office |
122 Emerald Hill Road Singapore 229405 |
| Secretary | Nor Hafiza Alwi |
| Registrar / Transfer Agent | B.A.C.S. PRIVATE LIMITED |
| Registrar Address | 77 Robinson Road, #06-03 Robinson 77, Singapore 068896 |
| Auditors | PKF-CAP LLP |
| Other Stock Exchange Listings | *SINGAPORE EXCHANGE (CATALIST) |
| Background | The Company was incorporated in Singapore on 19 July 2009 under the name of Biolidics Limited. On 19 December 2018, it was listed on the Catalist Board of the SGX-ST and on 24 June 2025 renamed Embracing Future Holdings Limited. The Company is an investment holding company. The Group's business are (i) in medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnostics, prognosis, treatment selection and treatment monitoring; (ii) involve the ownership, operation and management of MCN businesses and live streaming social e-commerce platforms; (iii) Esports-related businesses such as promotor of games, online event services; (iv) Green energy-related businesses and (v) Artificial Intelligence (AI) agent sectors. |
| Last Updated | 01/09/2026 08:45:30 AM |
| Country | SINGAPORE |
© 2026 Dividends.sg